GTT1500 | Glutathione | 99% White powder High Quality semaglutide weight CAS NO. 87805-34-3
TDS 12 Inquiries
87805-34-3
High Purity Grade
99%
Shenzhen
Tong Peptides
1500mg/vial, 10 vials/box
2027-03-12
retatrutide,TB-500,GHK-CU,peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceGLP-1 stimulates pancreatic β cells to secrete insulin as an incretin hormone. GLP-1 also has additional actions, including suppression of glucagon secretion, inhibition of gastric motility, and promotion of satiety.
GLP-1 was first identified in the early 1980s, following the cloning of the proglucagon gene. The biological activity of GLP-1 was investigated initially by using the N-terminal extended forms of GLP-1(1–37 and 1–36 amide). However, these forms were devoid of biological activity. In the late 1980s, bioactive GLP-1 peptides were purified from gut extracts and were identified to be GLP1(7–37) and GLP-1(7–36)-amide. In the current literature, the unqualified designation of GLP-1 corresponds to the truncated peptides.
Glucagon-Like Peptide I (GLP1) is an incretin hormone, which functions as ligand for GLP1 receptors (GLP1R). These receptors are expressed in renal and cardiovascular system, such as smooth muscle and endothelial cells.
Glucagon Like Peptide-1 is a single, non-glycosylated, polypeptide chain containing 30 amino acids and having a molecular mass of 3297.7 Dalton.The GLP-1 is purified by proprietary chromatographic techniques.CertificatesBasic Info-
Product Name:
GLP-1
Other Name:HIS-ASP-GLU-PHE-GLU-ARG-HIS-ALA-GLU-GLY- THR-PHE-THR-SER-ASP-VAL-SER-SER-TYR-LEU-GLU-GLY-GLN-ALA-ALA-LYS-GLU-PHE-ILE-ALA-TRP-LEU-VAL-LYS-GLY-ARGY-GLY;GLUCAGON-LIKE PEPTIDE I HUMAN;GLUCAGON-LIKE PEPTIDE-1, HUMAN;GLUCAGON-LIKE PEPTIDE I;GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN);GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT);GLUCAGON-LIKE PEPTIDE 1 (1-37) (HUMAN, BOVINE, GUINEA PIG, MOUSE, RAT) TRIFLUOROACETATE SALT;GLP-1
CAS No.:87805-34-3
Molecular Formula:C186H275N51O59
InChIKeys:UKVFVQPAANCXIL-FJVFSOETSA-N
Molecular Weight:4169.48
EC Number:201-258-5
HScode:3504009000
Categories:
Characteristics-
Water Solubility:
Soluble to 5 mg/ml in water
Critical Temperature & Pressure:−20°C
Research-
Class:
GLP-1R agonist
Status:FDA-approved (Ozempic / Wegovy / Rybelsus)
Mechanism:Long-acting, selective glucagon-like peptide-1 (GLP-1) receptor agonist with 94% sequence homology to human GLP-1. Engineered for extended half-life (~1 week) via albumin binding (fatty acid acylation at Lys26) and resistance to DPP-4 degradation (Aib substitution at position 8). Promotes insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces appetite via central nervous system GLP-1R activation.
Activity note:Potent, selective GLP-1R agonist. Reported binding affinity Ki = 0.38 ± 0.06 nM. Semaglutide is a human GLP-1 analog with structural modifications for albumin binding (C18 fatty diacid at Lys26) and enzymatic stability (Aib8 substitution).
Source:Lau J, et al. J Med Chem. 2015;58(18):7370-7380. Wilding JPH, et al. N Engl J Med. 2021;384(11):989-1002.DOI
Clinical Development:FDA:Ozempic, Wegovy, Rybelsus (approved 2017-12-05)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
NEJM: Wilding et al. (2021) — STEP-1; NEJM: Marso et al. (2016) — SUSTAIN-6; J Med Chem: Lau et al. (2015) — Discovery of Semaglutide; FDA: Ozempic (NDA 209637)
Disclaimer:Semaglutide is approved as a prescription medicine (Ozempic, Wegovy, Rybelsus) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
retatrutide,TB-500,GHK-CU,peptide
-
Location:
1-1, Kailuo Road, Taojia Town, Jiulongpo District, Chongqing
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
501-1000
-
Year of Establishment:
2023
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted 
China
GLP-1
1.00 KG Jul 17, 2026 
United States
GLP-1
1 KG Jun 5, 2025 
Australia
GLP-1
1.00 G Jul 17, 2026 
Philippines
GLP-1
15 MG Jul 14, 2026
United States
GLP 3
20 MG Feb 24, 2026
United States
99% Purity Reta Lyophilized Powder GLP-1 for Weight Loss
20 L Jan 8, 2026
Philippines
GLP-1
10 MG Jul 23, 2026
United States
glp1
30 MG Jul 1, 2026 
Thailand
GLP-3
300 MG Mar 10, 2026
United States
glp1
1 G Mar 10, 2026
United States
GLP-1
1 KG Feb 25, 2026
United States
glp1
1 KG Jan 5, 2026 Post an enquiry for this product
